Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 1.000 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.526 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.488 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.486 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.480 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.478 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.478 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.476 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.475 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.474 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.472 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.471 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.470 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.467 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.467 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.466 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.465 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.464 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.461 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.461 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.458 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.457 | |
| 1ml3 | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.456 | |
| 1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.456 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.456 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.453 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
| 1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.452 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.451 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.451 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.451 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.451 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.450 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.448 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.448 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.448 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.447 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.446 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.445 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.445 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 2nnh | REA | Cytochrome P450 2C8 | / | 0.443 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.443 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.442 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.440 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 |